EP0986557A4 - GONADOLIBERIN ANTAGONISTS - Google Patents

GONADOLIBERIN ANTAGONISTS

Info

Publication number
EP0986557A4
EP0986557A4 EP98923865A EP98923865A EP0986557A4 EP 0986557 A4 EP0986557 A4 EP 0986557A4 EP 98923865 A EP98923865 A EP 98923865A EP 98923865 A EP98923865 A EP 98923865A EP 0986557 A4 EP0986557 A4 EP 0986557A4
Authority
EP
European Patent Office
Prior art keywords
gonadoliberin
antagonists
gonadoliberin antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98923865A
Other languages
German (de)
French (fr)
Other versions
EP0986557A1 (en
Inventor
Mark Goulet
Feroze Ujjainwalla
Thomas F Walsh
Matthew J Wyvratt Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716865.2A external-priority patent/GB9716865D0/en
Priority claimed from GBGB9719391.6A external-priority patent/GB9719391D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0986557A1 publication Critical patent/EP0986557A1/en
Publication of EP0986557A4 publication Critical patent/EP0986557A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP98923865A 1997-06-05 1998-06-01 GONADOLIBERIN ANTAGONISTS Withdrawn EP0986557A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US4874397P 1997-06-05 1997-06-05
US4863597P 1997-06-05 1997-06-05
US48743P 1997-06-05
US48635P 1997-06-05
GBGB9716865.2A GB9716865D0 (en) 1997-08-08 1997-08-08 Antagonists of gonadotrophin releasing hormone
GB9716865 1997-08-08
GB9719391 1997-09-11
GBGB9719391.6A GB9719391D0 (en) 1997-09-11 1997-09-11 Antagonists of gonadotropin releasing hormone
PCT/US1998/011072 WO1998055479A1 (en) 1997-06-05 1998-06-01 Antagonists of gonadotropin releasing hormone

Publications (2)

Publication Number Publication Date
EP0986557A1 EP0986557A1 (en) 2000-03-22
EP0986557A4 true EP0986557A4 (en) 2001-03-14

Family

ID=27451687

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98923865A Withdrawn EP0986557A4 (en) 1997-06-05 1998-06-01 GONADOLIBERIN ANTAGONISTS

Country Status (5)

Country Link
EP (1) EP0986557A4 (en)
JP (1) JP2002502422A (en)
AU (1) AU729663B2 (en)
CA (1) CA2291647A1 (en)
WO (1) WO1998055479A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346534B1 (en) 1998-09-23 2002-02-12 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6537998B1 (en) 1999-10-15 2003-03-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
WO2001055119A2 (en) 2000-01-25 2001-08-02 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
JP2002080397A (en) * 2000-07-05 2002-03-19 Takeda Chem Ind Ltd Therapeutic pharmaceutical formulation for sex hormone-dependent disease
GB0022670D0 (en) 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
SE0100566D0 (en) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
SE0101692D0 (en) 2001-05-14 2001-05-14 Astrazeneca Ab Compounds
WO2003011870A1 (en) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
US6939883B2 (en) 2001-08-02 2005-09-06 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1411941A2 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
JP2005500352A (en) 2001-08-02 2005-01-06 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 1,2,4-triazine-3,5-diones as gonadotropin releasing hormone receptor (GnRH) antagonists
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
GB0219472D0 (en) 2002-08-21 2002-10-02 Astrazeneca Ab Chemical compounds
JP2006508050A (en) 2002-08-21 2006-03-09 アストラゼネカ アクチボラグ Thienopyrrole compounds as antagonists of gonadotropin releasing hormone
DE60314158T2 (en) 2002-08-21 2008-01-31 Astrazeneca Ab PYRAZONE DERIVATIVES AS GNRH INHIBITORS
TW200413351A (en) 2002-08-21 2004-08-01 Astrazeneca Ab Chemical compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
AU2004257639B2 (en) 2003-07-07 2011-01-06 Neurocrine Biosciences, Inc. Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
DE602004020638D1 (en) 2003-07-07 2009-05-28 Neurocrine Biosciences Inc PYRIMIDIN-2,4-DION DERIVATIVES AS GONADOTROPINE RELEASING HORMONE RECEPTOR ANTAGONISTS
ES2387495T3 (en) 2003-07-07 2012-09-25 Neurocrine Biosciences, Inc. Arylpyrimidines useful in the treatment of disorders related to sex hormones, such as endometriosis, prostate cancer and the like
DE102004033902A1 (en) 2004-07-14 2006-02-16 Zentaris Gmbh New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease
WO2007047397A2 (en) 2005-10-13 2007-04-26 Smithkline Beecham Corporation Phenol ethers as modulators of the opioid receptors
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (en) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
US10821152B2 (en) 2014-08-26 2020-11-03 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions
MX2021003904A (en) 2018-10-05 2021-10-26 Annapurna Bio Inc COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028405A1 (en) * 1994-04-19 1995-10-26 Takeda Chemical Industries, Ltd. Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1208412A (en) * 1995-12-14 1999-02-17 麦克公司 GnRH antagonists
SK77598A3 (en) * 1995-12-14 1999-01-11 Merck & Co Inc Nonpeptide derivatives, pharmaceutical composition containing them and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028405A1 (en) * 1994-04-19 1995-10-26 Takeda Chemical Industries, Ltd. Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9855479A1 *

Also Published As

Publication number Publication date
CA2291647A1 (en) 1998-12-10
EP0986557A1 (en) 2000-03-22
AU729663B2 (en) 2001-02-08
JP2002502422A (en) 2002-01-22
AU7605698A (en) 1998-12-21
WO1998055479A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
EP0986557A4 (en) GONADOLIBERIN ANTAGONISTS
EP0986385A4 (en) GONADOLIBERINE ANTAGONISTS
EP0868178A4 (en) GONADOLIBERIN ANTAGONISTS
MX208461B (en) THERMOFRAGUATED POLYSACARIDS
ATE250583T1 (en) SUBSTITUTED 3-CYANOCINOLINES
DE69819125D1 (en) Distinctive connection arrangement
DE69831181D1 (en) location
EP0984779A4 (en) STOMATOSTATIN AGONISTS
DE69734833D1 (en) VITRONEKTIN RECEPTOR ANTAGONISTS
DE69822740D1 (en) Interconnects
ID23168A (en) VITRONEKTIN ANATAGONICAL RECEPTORS
DE69819057D1 (en) Interconnects
DE69834906D1 (en) INTERCONNECTS
NO994850D0 (en) Pharmacological agents
EP1049472A4 (en) GONADOLIBERIN ANTAGONISTS
DE69829560D1 (en) INTERCONNECTS
DE59813487D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
PT981652E (en) BIOLIXIVIACAO DE CONCENTRADO MINERAL DE SULFURETO
PT1045691E (en) STATIN-ETER CARBOXYL-CHLORIC COMBINATIONS
EP0994900A4 (en) SEMAPHORIN RECEPTORS
DE69823611D1 (en) Interconnects
DE69838828D1 (en) Interconnects
DE59809844D1 (en) headbox
DE69808562D1 (en) Interconnects
ATE244705T1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 409/14 A, 7A 61K 31/44 B, 7C 07D 487/08 B, 7A 61P 5/02 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010124

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20010302